EZH2 expression is associated with high proliferation rate and aggresive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
| Authors |
|
|---|---|
| Publication date | 2006 |
| Journal | Journal of Clinical Oncology |
| Volume | Issue number | 24 |
| Pages (from-to) | 268-273 |
| Organisations |
|
| Document type | Article |
| Published at |
https://doi.org/10.1200/JCO.2005.01.5180
(Final published version)
|
| Permalink to this page | |